{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T22:41:27Z","timestamp":1793745687511,"version":"4.6.1"},"update-to":[{"DOI":"10.1002\/14651858.cd003961","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2005,10,19]],"date-time":"2005-10-19T00:00:00Z","timestamp":1129680000000}}],"reference-count":146,"publisher":"Wiley","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd003961.pub2","type":"journal-article","created":{"date-parts":[[2005,10,7]],"date-time":"2005-10-07T11:54:39Z","timestamp":1128686079000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":111,"title":["Tacrolimus versus cyclosporin as primary immunosuppression for kidney transplant recipients"],"prefix":"10.1002","author":[{"given":"Angela C","family":"Webster","sequence":"first","affiliation":[{"name":"University of Sydney; School of Public Health; Edward Ford Building A27 Sydney NSW Australia 2006"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rod RS","family":"Taylor","sequence":"additional","affiliation":[{"name":"Peninsula Medical School; PenTAG; Noy Scott House Barrack Road Exeter UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy R","family":"Chapman","sequence":"additional","affiliation":[{"name":"Westmead Hospital; Renal Medicine; Darcy Rd Westmead NSW Australia 2145"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan C","family":"Craig","sequence":"additional","affiliation":[{"name":"The Children's Hospital at Westmead; Centre for Kidney Research; Locked Bag 4001 Westmead NSW Australia 2145"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2005,10,19]]},"reference":[{"issue":"Program & Abstr","key":"10.1002\/14651858.CD003961.pub2-BIB0001|cit1","first-page":"847A","article-title":"Human polyoma virus infects a high proportion of renal allograft recipients and the incidence Is not affected by choice of calcineurin inhibitor [abstract]","volume":"12","author":"Agha","year":"2001","journal-title":"Journal of the American Society of Nephrology"},{"key":"10.1002\/14651858.CD003961.pub2-BIB0002|cit2","unstructured":"Baskin E Colak T Karakayali H Ozdemir FN Saatci U Haberal M Changes in serum cholesterol and triglyceride level in renal transplant recipient treated with cyclosporine or tacrolimus [abstract] XIXth International Congress of the Transplantation Society; 2002 Aug 25-30; Miami (USA) 2002"},{"issue":"8","key":"10.1002\/14651858.CD003961.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/00007890-200004271-00014","article-title":"Canadian Multicentre Trial Of Prograf\/AZA Vs. Prograf\/MMF Vs. Neoral\/MMF in Renal Transplantation [abstract]","volume":"69","author":"Busque","year":"2000","journal-title":"Transplantation"},{"issue":"1-2","key":"10.1002\/14651858.CD003961.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1016\/S0041-1345(00)02471-4","article-title":"Canadian multicentre trial of tacrolimus\/azathioprine\/steroids versus tacrolimus\/mycophenolate mofetil\/steroids versus neoral\/mycophenolate mofetil\/steroids in renal transplantation","volume":"33","author":"Busque","year":"2001","journal-title":"Transplantation Proceedings"},{"issue":"5","key":"10.1002\/14651858.CD003961.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1016\/S0041-1345(02)02968-8","article-title":"One-year follow-up of a Brazilian randomized multicenter study comparing tacrolimus versus cyclosporine in kidney transplantation","volume":"34","author":"Campos","year":"2002","journal-title":"Transplantation Proceedings"},{"issue":"5","key":"10.1002\/14651858.CD003961.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1016\/S0041-1345(02)03048-8","article-title":"A three arm study comparing immediate tacrolimus therapy with ATG induction therapy followed by either tacrolimus or cyclosporine in adult renal transplant recipients","volume":"34","author":"Charpentier","year":"2002","journal-title":"Transplantation Proceedings"},{"issue":"Program & Abstr","key":"10.1002\/14651858.CD003961.pub2-BIB0007|cit7","first-page":"916A","article-title":"Comparison of ATG induction followed by tacrolimus therapy with ATG induction followed by cyclosporine therapy, and immediate tacrolimus-based triple therapy [abstract]","volume":"12","author":"Rostaing","year":"2001","journal-title":"Journal of the American Society of Nephrology"},{"key":"10.1002\/14651858.CD003961.pub2-BIB0008|cit8","unstructured":"Egfjord M Ladefoged J Olgaard K Similar frequency of acute rejection, graft-and patient survival in quadruple therapy with tacrolimus versus cyclosporin in combination with prednisone, mycophenolate mofetil, and ATGAM after renal allotransplantation [abstract] XIXth International Congress of the Transplantation Society; 2002 Aug 25-30; Miami (USA) 2002"},{"issue":"Program & Abstr","key":"10.1002\/14651858.CD003961.pub2-BIB0009|cit9","first-page":"886A","article-title":"Changes in bone mineral density (BMD) in kidney transplant recipients receiving tacrolimus (FK506) versus cyclosporine (Cy-A) [abstract]","volume":"12","author":"Haggan","year":"2001","journal-title":"Journal of the American Society of Nephrology"},{"issue":"5","key":"10.1002\/14651858.CD003961.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1016\/S0041-1345(02)03094-4","article-title":"One year evolution of bone mineral density in kidney transplant recipients receiving tacrolimus versus cyclosporine","volume":"34","author":"Haggan","year":"2002","journal-title":"Transplantation Proceedings"},{"issue":"9","key":"10.1002\/14651858.CD003961.pub2-BIB0011|cit11","first-page":"1350","article-title":"Distal tubular acidosis induced by FK506 [abstract]","volume":"7","author":"Heering","year":"1996","journal-title":"Journal of the American Society of Nephrology"},{"issue":"5","key":"10.1002\/14651858.CD003961.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/j.1399-0012.1998.tb00998.x","article-title":"Distal tubular acidosis induced by FK506","volume":"12","author":"Heering","year":"1998","journal-title":"Clinical Transplantation"},{"issue":"2","key":"10.1002\/14651858.CD003961.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0021-9150(01)00438-5","article-title":"Changes in lipid metabolism and effect of simvastatin in renal transplant recipients induced by cyclosporine or tacrolimus","volume":"158","author":"Ichimaru","year":"2001","journal-title":"Atherosclerosis"},{"issue":"2","key":"10.1002\/14651858.CD003961.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/00007890-200107270-00014","article-title":"Randomized trial of tacrolimus plus mycophenolate mofetil or azathioprine versus cyclosporine oral solution (modified) plus mycophenolate mofetil after cadaveric kidney transplantation: results at 2 years","volume":"72","author":"Ahsan","year":"2001","journal-title":"Transplantation"},{"key":"10.1002\/14651858.CD003961.pub2-BIB0015|cit15","unstructured":"Gonwa TA For the FK506\/MMF Study Trial Group 2 year followup of a randomized trial of FK506 + MMF vs FK506 + AZA VS CyA + MMF [abstract] XVIII International Congress of the Transplantation Society; 2000 Aug 27-Sep 1; Rome (Italy) 2000"},{"issue":"8","key":"10.1002\/14651858.CD003961.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"S113","DOI":"10.1097\/00007890-200004271-00011","article-title":"Two year followup of randomised multicenter kidney transplant study comparing tacrolimus (PG) + azathioprine (AZA) vs cyclosporin (Neoral) + mycophenolate mofetil (MMF) vs tacrolimus + MMF [abstract]","volume":"69","author":"Gonwa","year":"2000","journal-title":"Transplantation"},{"issue":"5","key":"10.1002\/14651858.CD003961.pub2-BIB0018|cit17","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1097\/00007890-200003150-00028","article-title":"Randomized trial of tacrolimus (Prograf) in combination with azathioprine or mycophenolate mofetil versus cyclosporine (Neoral) with mycophenolate mofetil after cadaveric kidney transplantation","volume":"69","author":"Johnson","year":"2000","journal-title":"Transplantation"},{"issue":"Program & Abstr","key":"10.1002\/14651858.CD003961.pub2-BIB0017|cit18","first-page":"3","article-title":"Randomized trial of Prograf+MMF or azathioprine versus neoral+MMF after cadaveric kidney transplantation: Results at three years [abstract]","volume":"13","author":"Johnson","year":"2002","journal-title":"Journal of the American Society of Nephrology"},{"issue":"7","key":"10.1002\/14651858.CD003961.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1097\/00007890-199610150-00009","article-title":"Relationship of FK506 whole blood concentrations and efficacy and toxicity after liver and kidney transplantation","volume":"62","author":"Kershner","year":"1996","journal-title":"Transplantation"},{"issue":"1","key":"10.1002\/14651858.CD003961.pub2-BIB0020|cit20","first-page":"809","article-title":"Phase II FK 506 multicenter concentration control study: one-year follow-up","volume":"27","author":"Laskow","year":"1995","journal-title":"Transplantation Proceedings"},{"issue":"7","key":"10.1002\/14651858.CD003961.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1097\/00007890-199610150-00005","article-title":"An open-label, concentration-ranging trial of FK506 in primary kidney transplantation: a report of the United States Multicenter FK506 Kidney Transplant Group","volume":"62","author":"Laskow","year":"1996","journal-title":"Transplantation"},{"issue":"11","key":"10.1002\/14651858.CD003961.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1097\/00007890-199606150-00005","article-title":"One-year follow-up of an open-label trial of FK506 for primary kidney transplantation. A report of the U.S. Multicenter FK506 Kidney Transplant Group","volume":"61","author":"Vincenti","year":"1996","journal-title":"Transplantation"},{"issue":"1","key":"10.1002\/14651858.CD003961.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0041-1345(02)04003-4","article-title":"Randomized trial of tacrolimus in combination with mycophenolate mofetil versus cyclosporine with mycophenolate mofetil in cadaveric renal transplant recipients with delayed graft function","volume":"35","author":"Liu","year":"2003","journal-title":"Transplantation Proceedings"},{"key":"10.1002\/14651858.CD003961.pub2-BIB0024|cit24","doi-asserted-by":"crossref","unstructured":"Del Castillo Caba D For the European Tacrolimus vs Ciclosporin-ME Renal Transplant Study Group Analysis of primary and recurrent rejection following renal transplantation in a large comparative multicentre trial [abstract] XVIII International Congress of the Transplantation Society; 2000 Aug 27-Sep 1; Rome (Italy) 2000","DOI":"10.1016\/S0041-1345(00)02411-8"},{"issue":"1-2","key":"10.1002\/14651858.CD003961.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/S0041-1345(00)02411-8","article-title":"Analysis of primary and recurrent rejection following renal transplantation in a large, comparative, multicentre trial","volume":"33","author":"Castillo","year":"2001","journal-title":"Transplantation Proceedings"},{"issue":"8","key":"10.1002\/14651858.CD003961.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1097\/00007890-200004271-00966","article-title":"Analysis of primary and recurrent acute rejections after renal transplantation in age European multicentre trial involving tacrolimus and cyclosporin-microemulsion [abstract]","volume":"69","author":"Dietl","year":"2000","journal-title":"Transplantation"},{"issue":"5","key":"10.1002\/14651858.CD003961.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1016\/S0041-1345(02)02969-X","article-title":"Oral dosing of tacrolimus and cyclosporine microemulsion - Results from a large multicenter study in renal transplantation","volume":"34","author":"Dietl","year":"2002","journal-title":"Transplantation Proceedings"},{"key":"10.1002\/14651858.CD003961.pub2-BIB0028|cit28","unstructured":"Kraemer BK Montagnino G Arias MPJ Tacrolimus vs Cyclosporin Follow-up Study Group Tacrolimus vs. cyclosporin microemulsion: 3-year follow-up of a large, multicentre Trial [abstract] American Transplant Congress: 2003 May 30-Jun 4; Washington (USA) 2003"},{"issue":"Program & Abstr","key":"10.1002\/14651858.CD003961.pub2-BIB0029|cit29","first-page":"902A","article-title":"Cardiovascular risk in kidney transplantation in a randomized study comparing tacrolimus (TAC) and cyclosporin A microemulsion (CYA) [abstract]","volume":"12","author":"Kramer","year":"2001","journal-title":"Journal of the American Society of Nephrology"},{"issue":"5","key":"10.1002\/14651858.CD003961.pub2-BIB0030|cit30","first-page":"580","article-title":"Tacrolimus versus cyclosporin in renal transplantation in Italy: Cost-minimisation and cost-effectiveness analyses","volume":"15","author":"Lazzaro","year":"2002","journal-title":"Journal of Nephrology"},{"issue":"4","key":"10.1002\/14651858.CD003961.pub2-BIB0033|cit31","first-page":"611","article-title":"Tacrolimus vs ciclosporin microemulsion in renal transplantation. A randomized multicentre study","volume":"60","author":"Margreiter","year":"2002","journal-title":"Chirurgische Praxis"},{"issue":"9308","key":"10.1002\/14651858.CD003961.pub2-BIB0031|cit32","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S0140-6736(02)07875-3","article-title":"Efficacy and safety of tacrolimus compared with ciclosporin microemulsion in renal transplantation: a randomised multicentre study","volume":"359","author":"Margreiter","year":"2002","journal-title":"Lancet"},{"issue":"8","key":"10.1002\/14651858.CD003961.pub2-BIB0032|cit33","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1097\/00007890-200004271-00008","article-title":"A prospective, randomized, multicentre study to compare the efficacy and safety of tacrolimus and ciclosporin-microemulsion in renal transplantation [abstract]","volume":"69","author":"Margreiter","year":"2000","journal-title":"Transplantation"},{"issue":"5","key":"10.1002\/14651858.CD003961.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1016\/S0041-1345(02)02960-3","article-title":"Efficacy and safety of tacrolimus compared with cyclosporine microemulsion in kidney transplantation: twelve-month follow-up","volume":"34","author":"Montagnino","year":"2002","journal-title":"Transplantation Proceedings"},{"issue":"Program & Abstr","key":"10.1002\/14651858.CD003961.pub2-BIB0035|cit35","first-page":"700A","article-title":"A large, prospective study of tacrolimus vs. emulsified ciclosporin following renal transplantation [abstract]","volume":"11","author":"Olbricht","year":"2000","journal-title":"Journal of the American Society of Nephrology"},{"key":"10.1002\/14651858.CD003961.pub2-BIB0036|cit36","unstructured":"Ruiz San Millan JC Arias M Kraemer BK Montagnino G Tacrolimus versus ciclosporin-microemulsion in renal transplantation: the two year follow-up results [abstract] XIXth International Congress of the Transplantation Society; 2002 Aug 25-30; Miami (USA) 2002"},{"key":"10.1002\/14651858.CD003961.pub2-BIB0037|cit37","unstructured":"Salvadori M European Tacrolimus vs Cyclosporin-Microemulsion Renal Transplantation Study Group Detailed analysis of first and recurrent acute rejections in a large comparative, multicentre, European trial in renal transplantation [abstract] 38th European Renal Association - European Dialysis and Transplant Association Congress; 2001 Jun 24-27; Vienna (Austria) 2001"},{"issue":"1-2","key":"10.1002\/14651858.CD003961.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/S0041-1345(00)02477-5","article-title":"A large, multicentre trial to compare the efficacy and safety of tacrolimus with cyclosporine microemulsion following renal transplantation","volume":"33","author":"Sperschneider","year":"2001","journal-title":"Transplantation Proceedings"},{"key":"10.1002\/14651858.CD003961.pub2-BIB0039|cit39","unstructured":"Sperschneider H For the European Tacrolimus vs Ciclosporin-ME Study Group A Large Multicentre Trial To Compare The Efficacy and Safety of Tacrolimus and Ciclosporin-Microemulsion Following Renal [abstract] XVIII International Congress of the Transplantation Society; 2000 Aug 27-Sep 1; Rome (Italy) 2000"},{"issue":"4","key":"10.1002\/14651858.CD003961.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1016\/S0041-1345(98)00246-2","article-title":"Lipoprotein patterns in renal transplant patients: a comparison between FK 506 and cyclosporine A patients","volume":"30","author":"Claesson","year":"1998","journal-title":"Transplantation Proceedings"},{"issue":"4","key":"10.1002\/14651858.CD003961.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1046\/j.1463-1326.2001.00132.x","article-title":"Metabolic and hormonal effects of tacrolimus (FK506) or cyclosporin immunosuppression following renal transplantation","volume":"3","author":"Dmitrewski","year":"2001","journal-title":"Diabetes Obesity & Metabolism"},{"key":"10.1002\/14651858.CD003961.pub2-BIB0042|cit42","first-page":"S73","article-title":"Tacrolimus and cyclosporine efficacy in high-risk kidney transplantation. European Multicentre Tacrolimus (FK506) Renal Study Group","volume":"11 Suppl 1","author":"Hauser","year":"1998","journal-title":"Transplant International"},{"issue":"3","key":"10.1002\/14651858.CD003961.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1097\/00007890-199708150-00012","article-title":"Multicenter randomized trial comparing tacrolimus (FK506) and cyclosporine in the prevention of renal allograft rejection: a report of the European Tacrolimus Multicenter Renal Study Group","volume":"64","author":"Mayer","year":"1997","journal-title":"Transplantation"},{"issue":"7A","key":"10.1002\/14651858.CD003961.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1016\/S0041-1345(99)00789-7","article-title":"Four-year follow-up of the European Tacrolimus Multicenter Renal Study","volume":"31","author":"Mayer","year":"1999","journal-title":"Transplantation Proceedings"},{"key":"10.1002\/14651858.CD003961.pub2-BIB0045|cit45","unstructured":"Mayer D Tacrolimus vs cyclosporin in renal transplantation: five-year follow-up of the European multicentre study [abstract] American Transplant Congress, Transplant 2002; 2002 Apr 26-May 1; Washington (USA) 2002"},{"issue":"Program & Abstr","key":"10.1002\/14651858.CD003961.pub2-BIB0046|cit46","first-page":"738A","article-title":"Four year results of the European multicentre study comparing tacrolimus and cyclosporine for immunosuppression after cadaveric renal transplantation [abstract]","volume":"10","author":"Morales","year":"1999","journal-title":"Journal of the American Society of Nephrology"},{"issue":"9","key":"10.1002\/14651858.CD003961.pub2-BIB0047|cit47","first-page":"1917","article-title":"Randomised trial comparing tacrolimus and cyclosporin in the prevention of renal allograft rejection. European Study [abstract]","volume":"7","author":"Morales","year":"1996","journal-title":"Journal of the American Society of Nephrology"},{"issue":"2","key":"10.1002\/14651858.CD003961.pub2-BIB0048|cit48","first-page":"86","article-title":"FK 506 versus cyclosporin in the prevention of renal allograft rejection--European pilot study: six-week results","volume":"8","author":"Schleibner","year":"1995","journal-title":"Transplant International"},{"issue":"4","key":"10.1002\/14651858.CD003961.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/S0041-1345(98)00234-6","article-title":"Factors affecting the pharmacokinetics of tacrolimus in the first year after renal transplantation. European Tacrolimus Multicentre Renal Study Group","volume":"30","author":"Undre","year":"1998","journal-title":"Transplantation Proceedings"},{"issue":"5","key":"10.1002\/14651858.CD003961.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1016\/S0041-1345(02)03042-7","article-title":"Randomized trial of three different immunosuppressive regimens to prevent chronic renal allograft rejection","volume":"34","author":"Burke","year":"2002","journal-title":"Transplantation Proceedings"},{"issue":"2","key":"10.1002\/14651858.CD003961.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/01.TP.0000101290.20629.DC","article-title":"A randomized long-term trial of tacrolimus and sirolimus versus tacrolimus and mycophenolate mofetil versus cyclosporine (NEORAL) and sirolimus in renal transplantation. I. Drug interactions and rejection at one year","volume":"77","author":"Ciancio","year":"2004","journal-title":"Transplantation"},{"issue":"2","key":"10.1002\/14651858.CD003961.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1097\/01.TP.0000101495.22734.07","article-title":"A randomized long-term trial of tacrolimus\/sirolimus versus tacrolimus\/mycophenolate mofetil versus cyclosporine (NEORAL)\/sirolimus in renal transplantation. II. Survival, function, and protocol compliance at 1 year","volume":"77","author":"Ciancio","year":"2004","journal-title":"Transplantation"},{"key":"10.1002\/14651858.CD003961.pub2-BIB0053|cit53","unstructured":"Mattiazzi A Burke GW Miller J Ciancio G Surgical complications after kidney transplantation: Comparing three different immunosuppressive regimenes [abstract] American Transplant Congress: 2003 May 30-Jun 4; Washington (USA) 2003"},{"key":"10.1002\/14651858.CD003961.pub2-BIB0054|cit54","unstructured":"Miller J Burke GW Ciancio G Blomberg BB Rosen A Roth D Randomized trial of three different immunosuppressive regimens to prevent chronic renal allograft rejection [abstract] XIXth International Congress of the Transplantation Society; 2002 Aug 25-30; Miami (USA) 2002"},{"issue":"2","key":"10.1002\/14651858.CD003961.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1046\/j.1523-1755.2002.00149.x","article-title":"Molecular and structural consequences of early renal allograft injury","volume":"61","author":"Baboolal","year":"2002","journal-title":"Kidney International"},{"issue":"7A","key":"10.1002\/14651858.CD003961.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S0041-1345(99)00798-8","article-title":"Immunological and nonimmunological risk factors with tacrolimus and Neoral in renal transplant recipients: an interim report","volume":"31","author":"Jurewicz","year":"1999","journal-title":"Transplantation Proceedings"},{"issue":"4","key":"10.1002\/14651858.CD003961.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/S0041-1345(98)00248-6","article-title":"Prospective randomized study comparing FK 506 (Prograft) and cyclosporine A (Neoral) as primary immunosuppression in cadaveric renal transplants at a single institution: interim report of the first 80 cases","volume":"30","author":"Morris-Stiff","year":"1998","journal-title":"Transplantation Proceedings"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD003961.pub2-BIB0058|cit58","first-page":"30","article-title":"Randomized trial of Prograf versus Neoral in cadaveric renal transplantation: 189 patients with a minimum 1-year follow-up [abstract]","volume":"87","author":"Morris-Stiff","year":"2000","journal-title":"British Journal of Surgery"},{"key":"10.1002\/14651858.CD003961.pub2-BIB0059|cit59","doi-asserted-by":"crossref","unstructured":"Quiroga I Morris-Stiff G Baboo R Darby C Lord R Jurewicz A Differential homocysteine levels in renal transplant patients receiving neoral vs tacrolimus [abstract] XVIII International Congress of the Transplantation Society; 2000 Aug 27-Sep 1; Rome (Italy) 2000","DOI":"10.1016\/S0041-1345(00)02389-7"},{"issue":"1-2","key":"10.1002\/14651858.CD003961.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/S0041-1345(00)02389-7","article-title":"Differential homocysteine levels in renal transplant patients receiving neoral versus tacrolimus","volume":"33","author":"Quiroga","year":"2001","journal-title":"Transplantation Proceedings"},{"issue":"7","key":"10.1002\/14651858.CD003961.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"2824","DOI":"10.1016\/S0041-1345(02)03530-3","article-title":"Arterial hypertension in renal transplant recipients treated with tacrolimus or cyclosporine-neoral","volume":"34","author":"Nichelle","year":"2002","journal-title":"Transplantation Proceedings"},{"issue":"1","key":"10.1002\/14651858.CD003961.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1097\/00007890-199801150-00028","article-title":"Commentary on a comparison of tacrolimus and cyclosporine for immunosuppression after cadaveric renal transplantation [letters]","volume":"65","author":"Cavaille-Coll","year":"1998","journal-title":"Transplantation"},{"issue":"6","key":"10.1002\/14651858.CD003961.pub2-BIB0063|cit63","first-page":"281","article-title":"Prograf(TM) (Tacrolimus). II. Prevention of acute graft rejection during kidney and liver transplantation","volume":"26","author":"Chevrel","year":"1997","journal-title":"Medecine et Chirurgie Digestives"},{"key":"10.1002\/14651858.CD003961.pub2-BIB0064|cit64","unstructured":"Filo R Tacrolimus in kidney transplantation: Two-year results of the U.S., randomized, comparative, phase III study [abstract] ASTP Meeting Abstracts 1997"},{"issue":"4","key":"10.1002\/14651858.CD003961.pub2-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/S0041-1345(98)00216-4","article-title":"Tacrolimus (FK 506) in kidney transplantation: three-year survival results of the US multicenter, randomized, comparative trial. FK 506 Kidney Transplant Study Group","volume":"30","author":"Jensik","year":"1998","journal-title":"Transplantation Proceedings"},{"issue":"1-2","key":"10.1002\/14651858.CD003961.pub2-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/S0041-1345(96)00270-9","article-title":"FK 506 in kidney transplantation: results of the U.S.A. randomized comparative phase III study. The FK 506 Kidney Transplant Study Group","volume":"29","author":"Miller","year":"1997","journal-title":"Transplantation Proceedings"},{"issue":"4","key":"10.1002\/14651858.CD003961.pub2-BIB0068|cit67","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/S0041-1345(98)00274-7","article-title":"Effect of race and immunosuppression in renal transplantation: three-year survival results from a US multicenter, randomized trial. FK506 Kidney Transplant Study Group","volume":"30","author":"Neylan","year":"1998","journal-title":"Transplantation Proceedings"},{"issue":"4","key":"10.1002\/14651858.CD003961.pub2-BIB0069|cit68","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1097\/00007890-199802270-00011","article-title":"Racial differences in renal transplantation after immunosuppression with tacrolimus versus cyclosporine. FK506 Kidney Transplant Study Group","volume":"65","author":"Neylan","year":"1998","journal-title":"Transplantation"},{"issue":"5","key":"10.1002\/14651858.CD003961.pub2-BIB0067|cit69","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/S0272-6386(98)70132-5","article-title":"Assessment of the frequency and costs of posttransplantation hospitalizations in patients receiving tacrolimus versus cyclosporine","volume":"32","author":"Neylan","year":"1998","journal-title":"American Journal of Kidney Diseases"},{"issue":"8","key":"10.1002\/14651858.CD003961.pub2-BIB0072|cit70","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1097\/00007890-199910270-00024","article-title":"Cytomegalovirus infection and posttransplant lymphoproliferative disease in renal transplant recipients: results of the U.S. multicenter FK506 Kidney Transplant Study Group","volume":"68","author":"Pirsch","year":"1999","journal-title":"Transplantation"},{"issue":"7","key":"10.1002\/14651858.CD003961.pub2-BIB0070|cit71","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1097\/00007890-199704150-00013","article-title":"A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. FK506 Kidney Transplant Study Group","volume":"63","author":"Pirsch","year":"1997","journal-title":"Transplantation"},{"issue":"8","key":"10.1002\/14651858.CD003961.pub2-BIB0071|cit72","doi-asserted-by":"crossref","first-page":"S113","DOI":"10.1097\/00007890-200004271-00010","article-title":"Tacrolimus versus cyclosporine in kidney transplantation: Five-year survival results of the US multicenter, randomized, comparative study [abstract]","volume":"69","author":"Pirsch","year":"2000","journal-title":"Transplantation"},{"issue":"12","key":"10.1002\/14651858.CD003961.pub2-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1097\/00007890-199712270-00020","article-title":"Assessment of health-related quality of life in kidney transplant patients receiving tacrolimus (FK506)-based versus cyclosporine-based immunosuppression. FK506 Kidney Transplant Study Group","volume":"64","author":"Shield","year":"1997","journal-title":"Transplantation"},{"issue":"12","key":"10.1002\/14651858.CD003961.pub2-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1097\/00007890-199812270-00029","article-title":"Histopathologic findings from 2-year protocol biopsies from a U.S. multicenter kidney transplant trial comparing tacrolimus versus cyclosporine: a report of the FK506 Kidney Transplant Study Group","volume":"66","author":"Solez","year":"1998","journal-title":"Transplantation"},{"issue":"1-2","key":"10.1002\/14651858.CD003961.pub2-BIB0077|cit75","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/S0041-1345(00)02312-5","article-title":"Tacrolimus (FK 506) in kidney transplantation: five-year survival results of the U.S. multicenter, randomized, comparative trial","volume":"33","author":"Vincenti","year":"2001","journal-title":"Transplantation Proceedings"},{"issue":"5","key":"10.1002\/14651858.CD003961.pub2-BIB0075|cit76","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1097\/00007890-200203150-00021","article-title":"A long-term comparison of tacrolimus (FK506) and cyclosporine in kidney transplantation: evidence for improved allograft survival at five years. [erratum appears in Transplantation 2002 Apr 27;73(8):1370.]","volume":"73","author":"Vincenti","year":"2002","journal-title":"Transplantation"},{"key":"10.1002\/14651858.CD003961.pub2-BIB0076|cit77","unstructured":"Vincenti F The Tacrolimus Kidney Transplant Study Group Tacrolimus versus cyclosporine in kidney transplantation: Five year results of the U.S. multicenter, randomized, comparative study [abstract] XVIII International Congress of the Transplantation Society; 2000 Aug 27-Sep 1; Rome (Italy) 2000"},{"issue":"9","key":"10.1002\/14651858.CD003961.pub2-BIB0078|cit78","first-page":"1920","article-title":"Systemic and renal hemodynamic effects of FK 506 and cyclosporine (CSA) in renal transplantation: a prospective randomized long-term study [abstract]","volume":"7","author":"Radermacher","year":"1996","journal-title":"Journal of the American Society of Nephrology"},{"issue":"1","key":"10.1002\/14651858.CD003961.pub2-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1432-2277.1998.tb00948.x","article-title":"Pronounced renal vasoconstriction and systemic hypertension in renal transplant patients treated with cyclosporin A versus FK 506","volume":"11","author":"Radermacher","year":"1998","journal-title":"Transplant International"},{"issue":"4","key":"10.1002\/14651858.CD003961.pub2-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0002-9610(99)00042-2","article-title":"A prospective randomized trial comparing the efficacy of tacrolimus versus cyclosporine in black recipients of primary cadaveric renal transplants","volume":"177","author":"Raofi","year":"1999","journal-title":"American Journal of Surgery"},{"issue":"6","key":"10.1002\/14651858.CD003961.pub2-BIB0081|cit81","first-page":"3169","article-title":"New onset of diabetes in FK 506 vs cyclosporine-treated kidney transplant recipients","volume":"23","author":"Scantlebury","year":"1991","journal-title":"Transplantation Proceedings"},{"issue":"6","key":"10.1002\/14651858.CD003961.pub2-BIB0082|cit82","first-page":"3065","article-title":"FK 506 in clinical kidney transplantation","volume":"23","author":"Shapiro","year":"1991","journal-title":"Transplantation Proceedings"},{"issue":"Program & Abstr","key":"10.1002\/14651858.CD003961.pub2-BIB0083|cit83","first-page":"950A","article-title":"Tacrolimus- vs cyclosporin microemulsion-based treatment in renal transplantation: Comparison with third month protocol biopsies [abstract]","volume":"12","author":"Toz","year":"2001","journal-title":"Journal of the American Society of Nephrology"},{"issue":"Programs and Ab","key":"10.1002\/14651858.CD003961.pub2-BIB0088|cit84","first-page":"569","article-title":"One-year GFR predicts graft survival in paediatric renal recipients: a randomised trial of tacrolimus vs cyclosporin [abstract]","volume":"13","author":"Filler","year":"2002","journal-title":"Journal of the American Society of Nephrology"},{"issue":"8","key":"10.1002\/14651858.CD003961.pub2-BIB0084|cit85","first-page":"C178","article-title":"Randomized, controlled trial comparing tacrolimus with neoral after renal transplantation [abstract]","volume":"16","author":"Filler","year":"2001","journal-title":"Pediatric Nephrology"},{"issue":"Suppl","key":"10.1002\/14651858.CD003961.pub2-BIB0085|cit86","first-page":"56","article-title":"One-year GFR predicts graft survival in paediatric renal recipients: A randomised trial of tacrolimus vs. cyclosporin microemulsion [abstract]","volume":"17","author":"Filler","year":"2002","journal-title":"Pediatric Nephrology"},{"issue":"8","key":"10.1002\/14651858.CD003961.pub2-BIB0086|cit87","first-page":"55","article-title":"Randomized trial of tacrolimus therapy vs. microemulsified cyclosporin in kidney transplantation [abstract]","volume":"16","author":"Filler","year":"2001","journal-title":"Pediatric Nephrology"},{"issue":"5","key":"10.1002\/14651858.CD003961.pub2-BIB0087|cit88","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1016\/S0041-1345(02)03128-7","article-title":"One-year glomerular filtration rate predicts graft survival in pediatric renal recipients: a randomized trial of tacrolimus vs cyclosporine microemulsion","volume":"34","author":"Filler","year":"2002","journal-title":"Transplantation Proceedings"},{"issue":"3","key":"10.1002\/14651858.CD003961.pub2-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s00467-001-0795-9","article-title":"Randomized trial of tacrolimus versus cyclosporin microemulsion in renal transplantation","volume":"17","author":"Trompeter","year":"2002","journal-title":"Pediatric Nephrology"},{"key":"10.1002\/14651858.CD003961.pub2-BIB0090|cit90","unstructured":"Watson AR Filler G Webb NJ Randomised, multicentre European trial of tacrolimus vs microemulsified cyclosporin in paediatric renal transplantation: the 1-year results [abstract] XIXth International Congress of the Transplantation Society; 2002 Aug 25-30; Miami (USA) 2002"},{"key":"10.1002\/14651858.CD003961.pub2-BIB0091|cit91","unstructured":"Webb N Analysis of dosing and blood levels in the first large, multicentre, comparative trial of tacrolimus vs cyclosporin microemulsion in pediatric renal transplantation [abstract] XIXth International Congress of the Transplantation Society; 2002 Aug 25-30; Miami (USA) 2002"},{"key":"10.1002\/14651858.CD003961.pub2-BIB0092|cit92","unstructured":"Tsinalis D Binet I Dickenmann M Steiger J Brunner F Thiel G Cost of medical care after renal transplantation comparing cyclosporine-mycophenolate to tacrolimus-azathioprine - a randomised controlled study [abstract] XVIII International Congress of the Transplantation Society; 2000 Aug 27-Sep 1; Rome (Italy) 2000"},{"issue":"1","key":"10.1002\/14651858.CD003961.pub2-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1681\/ASN.V131213","article-title":"Glucose metabolism in the first 3 years after renal transplantation in patients receiving tacrolimus versus cyclosporine-based immunosuppression","volume":"13","author":"Duijnhoven","year":"2002","journal-title":"Journal of the American Society of Nephrology"},{"issue":"7","key":"10.1002\/14651858.CD003961.pub2-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1016\/S0041-1345(00)01408-1","article-title":"Tacrolimus vs CyA Neoral in combination with MMF and steroids after cadaveric renal transplantation","volume":"32","author":"Wang","year":"2000","journal-title":"Transplantation Proceedings"},{"issue":"6","key":"10.1002\/14651858.CD003961.pub2-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1016\/S0041-1345(02)03278-5","article-title":"Effects of three immunosuppressive regimens on CD4 helper function, B cell monocyte and cytokine responses in renal transplant recipients: 4-Month follow-up of a prospective randomized study","volume":"34","author":"Weimer","year":"2002","journal-title":"Transplantation Proceedings"},{"issue":"11","key":"10.1002\/14651858.CD003961.pub2-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1046\/j.1365-2168.2000.01577.x","article-title":"Differential effects of cyclosporin and tacrolimus on the expression of fibrosis-associated genes in isolated glomeruli from renal transplants","volume":"87","author":"Bicknell","year":"2000","journal-title":"British Journal of Surgery"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD003961.pub2-BIB0097|cit97","first-page":"82","article-title":"Analysis of side effects after renal transplantation using either tacrolimus or Neoral immunosuppression - a prospective randomized trial [abstract]","volume":"87","author":"Murphy","year":"2000","journal-title":"British Journal of Surgery"},{"issue":"6","key":"10.1002\/14651858.CD003961.pub2-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1002\/bjs.4134","article-title":"Randomized clinical trial of the effect of microemulsion cyclosporin and tacrolimus on renal allograft fibrosis","volume":"90","author":"Murphy","year":"2003","journal-title":"British Journal of Surgery"},{"issue":"5","key":"10.1002\/14651858.CD003961.pub2-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/S0041-1345(02)03033-6","article-title":"Primary immunosuppression with tacrolimus is associated with a reduction in renal allograft fibrosis compared with neoral therapy","volume":"34","author":"Waller","year":"2002","journal-title":"Transplantation Proceedings"},{"key":"10.1002\/14651858.CD003961.pub2-BIB0100|cit100","unstructured":"Waller JR White SA Murphy GJ Bicknell GR Sanford RS Nicholson ML Primary immunosuppression with tacrolimus is associated with a reduction in renal allograft fibrosis compared with neoral therapy [abstract] XIXth International Congress of the Transplantation Society; 2002 Aug 25-30; Miami (USA) 2002"},{"issue":"1","key":"10.1002\/14651858.CD003961.pub2-BIB0101|cit101","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0041-1345(99)00856-8","article-title":"Effect of acute rejection on expression of fibrosis associated genes in renal transplant recipients","volume":"32","author":"White","year":"2000","journal-title":"Transplantation Proceedings"},{"issue":"3","key":"10.1002\/14651858.CD003961.pub2-BIB0102|cit102","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/S0041-1345(00)00910-6","article-title":"Randomized trial comparing neoral and tacrolimus immunosuppression for recipients of renal transplants procured from different donor groups","volume":"32","author":"White","year":"2000","journal-title":"Transplantation Proceedings"},{"issue":"1","key":"10.1002\/14651858.CD003961.pub2-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S0041-1345(99)00934-3","article-title":"Preliminary analysis of a randomized trial comparing microemulsion cyclosporine and tacrolimus for recipients of renal transplants from non-heart-beating donors","volume":"32","author":"Williams","year":"2000","journal-title":"Transplantation Proceedings"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD003961.pub2-BIB0104|cit104","first-page":"74","article-title":"A randomized trial comparing Neoral (cyclosporin) and Tacrolimus immunosuppression for recipients of renal transplants procured from different donor groups [abstract]","volume":"86","author":"Williams","year":"1999","journal-title":"British Journal of Surgery"},{"issue":"Program & Abstr","key":"10.1002\/14651858.CD003961.pub2-BIB0105|cit105","first-page":"671","article-title":"A randomized, prospective, comparative trial of tacrolimus-mycophenolate mofetil and Neoral\u00ae-mycophenolate mofetil in kidney transplantation [abstract]","volume":"8","author":"Ahsan","year":"1997","journal-title":"Journal of the American Society of Nephrology"},{"issue":"Program & Abstr","key":"10.1002\/14651858.CD003961.pub2-BIB0106|cit106","first-page":"661","article-title":"New strategies using \"low-dose\" mycophenolate mofetil to further reduce acute rejection in patients after kidney transplantation - 1 year follow-up of a prospective, randomized clinical trial [abstract]","volume":"9","author":"Ahsan","year":"1998","journal-title":"Journal of the American Society of Nephrology"},{"issue":"2","key":"10.1002\/14651858.CD003961.pub2-BIB0107|cit107","doi-asserted-by":"crossref","first-page":"114","DOI":"10.7182\/prtr.1.9.2.t4l566l63m0g1126","article-title":"New strategies using 'low-dose' mycophenolate mofetil to reduce acute rejection in patients following kidney transplantation","volume":"9","author":"Ulsh","year":"1999","journal-title":"Journal of Transplant Coordination"},{"issue":"1-2","key":"10.1002\/14651858.CD003961.pub2-BIB0108|cit108","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/S0041-1345(98)01929-0","article-title":"Tacrolimus\/\"low-dose\" mycophenolate mofetil versus microemulsion cyclosporine\/\"low-dose\" mycophenolate mofetil after kidney transplantation--1-year follow-up of a prospective, randomized clinical trial","volume":"31","author":"Yang","year":"1999","journal-title":"Transplantation Proceedings"},{"issue":"7","key":"10.1002\/14651858.CD003961.pub2-BIB0109|cit109","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1016\/S0041-1345(00)01405-6","article-title":"Clinical experience with Prograf (tacrolimus, FK 506) in Chinese patients after renal transplantation","volume":"32","author":"Yu","year":"2000","journal-title":"Transplantation Proceedings"},{"key":"10.1002\/14651858.CD003961.pub2-BIB0110|cit110","unstructured":"Australia New Zealand Dialysis Transplant Registry ANZDATA Registry 24th Report http:\/\/www.anzdata.org.au\/ (accessed October 2002)"},{"issue":"3","key":"10.1002\/14651858.CD003961.pub2-BIB0111|cit111","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/sim.1023","article-title":"Individual patient- versus group-level data meta-regressions for the investigation of treatment effect modifiers: ecological bias rears its ugly head","volume":"21","author":"Berlin","year":"2002","journal-title":"Statistics in Medicine"},{"issue":"1","key":"10.1002\/14651858.CD003961.pub2-BIB0112|cit112","first-page":"55","article-title":"Pediatric renal transplantation: a review of the UNOS data. United Network for Organ Sharing","volume":"1","author":"Cecka","year":"1997","journal-title":"Pediatric Transplantation"},{"issue":"7406","key":"10.1002\/14651858.CD003961.pub2-BIB0113|cit113","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1136\/bmj.327.7406.65","article-title":"Balancing benefits and harms in health care","volume":"327","author":"Cuervo","year":"2003","journal-title":"BMJ"},{"issue":"2","key":"10.1002\/14651858.CD003961.pub2-BIB0114|cit114","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0272-6386(00)70348-9","article-title":"Nephrotoxicity of immunosuppressive drugs: long-term consequences and challenges for the future","volume":"35","author":"Mattos","year":"2000","journal-title":"American Journal of Kidney Diseases"},{"key":"10.1002\/14651858.CD003961.pub2-BIB0115|cit115","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/9780470693926.ch15","article-title":"Statistical methods for examining heterogeneity and combining results from several studies in meta-analysis","volume-title":"Systematic reviews in healthcare","author":"Deeks","year":"2001"},{"issue":"9158","key":"10.1002\/14651858.CD003961.pub2-BIB0116|cit116","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/S0140-6736(98)07493-5","article-title":"Immunosuppressive strategies in transplantation","volume":"353","author":"Denton","year":"1999","journal-title":"Lancet"},{"issue":"6964","key":"10.1002\/14651858.CD003961.pub2-BIB0117|cit117","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1136\/bmj.309.6964.1286","article-title":"Identifying relevant studies for systematic reviews","volume":"309","author":"Dickersin","year":"1994","journal-title":"BMJ"},{"issue":"7109","key":"10.1002\/14651858.CD003961.pub2-BIB0118|cit118","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD003961.pub2-BIB0119|cit119","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/9780470693926.ch3","article-title":"Problems and limitations in conducting systematic reviews","volume-title":"Systematic reviews in healthcare","author":"Egger","year":"2001"},{"issue":"5","key":"10.1002\/14651858.CD003961.pub2-BIB0120|cit120","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/S0952-7915(02)00386-2","article-title":"Late deterioration of organ transplants: a problem in injury and homeostasis","volume":"14","author":"Gourishankar","year":"2002 Oct","journal-title":"Current Opinion in Immunology"},{"issue":"8","key":"10.1002\/14651858.CD003961.pub2-BIB0121|cit121","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1034\/j.1600-6143.2003.00176.x","article-title":"Evolution of endpoints for renal transplant outcome","volume":"3","author":"Hariharan","year":"2003","journal-title":"American Journal of Transplantation"},{"issue":"4","key":"10.1002\/14651858.CD003961.pub2-BIB0122|cit122","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1046\/j.1600-6143.2003.00372.x","article-title":"New onset diabetes mellitus in patients receiving calcineurin inhibitors: a systematic review and meta-analysis","volume":"4","author":"Heisel","year":"2004","journal-title":"American Journal of Transplantation"},{"issue":"3","key":"10.1002\/14651858.CD003961.pub2-BIB0123|cit123","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1034\/j.1399-0012.1999.130301.x","article-title":"Cyclosporine and tacrolimus (FK506): a comparison of efficacy and safety profiles","volume":"13","author":"Henry","year":"1999","journal-title":"Clinical Transplantation"},{"key":"10.1002\/14651858.CD003961.pub2-BIB0124|cit124","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"issue":"2","key":"10.1002\/14651858.CD003961.pub2-BIB0125|cit125","first-page":"108","article-title":"Immunosuppressive agents in organ transplantation: past, present and future","volume":"20","author":"Hong","year":"2000","journal-title":"Seminars in Nephrology"},{"issue":"9","key":"10.1002\/14651858.CD003961.pub2-BIB0126|cit126","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1681\/ASN.V1191735","article-title":"Explained and unexplained ischemic heart disease risk after renal transplantation","volume":"11","author":"Kasiske","year":"2000","journal-title":"Journal of the American Society of Nephrology"},{"issue":"2","key":"10.1002\/14651858.CD003961.pub2-BIB0127|cit127","first-page":"176","article-title":"Cardiovascular disease after renal transplantation","volume":"20","author":"Kasiske","year":"2000","journal-title":"Seminars in Nephrology"},{"issue":"7191","key":"10.1002\/14651858.CD003961.pub2-BIB0128|cit128","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1136\/bmj.318.7191.1104","article-title":"Tacrolimus versus cyclosporin for immunosuppression in renal transplantation: meta-analysis of randomised trials","volume":"318","author":"Knoll","year":"1999","journal-title":"BMJ"},{"issue":"4","key":"10.1002\/14651858.CD003961.pub2-BIB0129|cit129","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1600-6143.2004.00386.x","article-title":"Biomarkers and surrogate endpoints in renal transplantation: present status and considerations for clinical trial design","volume":"4","author":"Lachenbruch","year":"2004","journal-title":"American Journal of Transplantation"},{"key":"10.1002\/14651858.CD003961.pub2-BIB0130|cit130","unstructured":"Lefebvre C McDonald S Development of a sensitive search strategy for reports of randomised controlled trials in EMBASE Fourth International Cochrane Colloquium; 1996 Oct 20-24; Adelaide (Australia) 1996"},{"key":"10.1002\/14651858.CD003961.pub2-BIB0131|cit131","first-page":"105","article-title":"Renal transplant outcome beyond 5 years","volume-title":"ANZDATA Registry Report","author":"Mathew","year":"2001"},{"issue":"3","key":"10.1002\/14651858.CD003961.pub2-BIB0132|cit132","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/j.1600-6143.2004.00332.x","article-title":"Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era","volume":"4","author":"Meier-Kriesche","year":"2004","journal-title":"American Journal of Transplantation"},{"issue":"24","key":"10.1002\/14651858.CD003961.pub2-BIB0133|cit133","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1056\/NEJMoa020009","article-title":"The natural history of chronic allograft nephropathy","volume":"349","author":"Nankivell","year":"2003","journal-title":"New England Journal of Medicine"},{"issue":"4","key":"10.1002\/14651858.CD003961.pub2-BIB0134|cit134","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1097\/01.TP.0000128636.70499.6E","article-title":"Calcineurin inhibitor nephrotoxicity: longitudinal assessment by protocol histology","volume":"78","author":"Nankivell","year":"2004","journal-title":"Transplantation"},{"key":"10.1002\/14651858.CD003961.pub2-BIB0135|cit135","unstructured":"Immunosuppresive therapy for renal transplantation in adults London: National Institute for Clinical Excellence; 2004 Sep 22. Report No.: 85"},{"issue":"5","key":"10.1002\/14651858.CD003961.pub2-BIB0136|cit136","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1038\/ki.1995.452","article-title":"Inferior outcome of two-haplotype matched renal transplants in blacks: role of early rejection","volume":"48","author":"Ojo","year":"1995","journal-title":"Kidney International"},{"issue":"8","key":"10.1002\/14651858.CD003961.pub2-BIB0137|cit137","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1056\/NEJMra011295","article-title":"Strategies to improve long-term outcomes after renal transplantation","volume":"346","author":"Pascual","year":"2002","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"10.1002\/14651858.CD003961.pub2-BIB0138|cit138","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1034\/j.1399-0012.2002.00071.x","article-title":"Quality of life in kidney recipients: comparison of tacrolimus and cyclosporine-microemulsion","volume":"16","author":"Reimer","year":"2002 Feb","journal-title":"Clinical Transplantation"},{"issue":"6","key":"10.1002\/14651858.CD003961.pub2-BIB0139|cit139","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1056\/NEJM199408113310606","article-title":"Renal transplantation","volume":"331","author":"Suthanthiran","year":"1994","journal-title":"New England Journal of Medicine"},{"issue":"11","key":"10.1002\/14651858.CD003961.pub2-BIB0140|cit140","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1002\/sim.1187","article-title":"How should meta-regression analyses be undertaken and interpreted?","volume":"21","author":"Thompson","year":"2002","journal-title":"Statistics in Medicine"},{"issue":"12","key":"10.1002\/14651858.CD003961.pub2-BIB0141|cit141","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1001\/jama.290.12.1624","article-title":"Practical clinical trials; increasing the value of clinical research for decision making in clinical and health policy","volume":"290","author":"Tunis","year":"2003","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD003961.pub2-BIB0142|cit142","unstructured":"Rockville M Richmond V 2000 Annual Report of the US Scientific Registry of Transplant Recipients and the Organ Procurement and Transplantation Network: Transplant data 1989-1998 http:\/\/www.unos.org (accessed October 2002)"},{"issue":"6","key":"10.1002\/14651858.CD003961.pub2-BIB0143|cit143","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1097\/00041552-199911000-00003","article-title":"Which calcineurin inhibitor is preferred in renal transplantation: tacrolimus or cyclosporine?","volume":"8","author":"Vanrenterghem","year":"1999","journal-title":"Current Opinion in Nephrology & Hypertension"},{"issue":"6","key":"10.1002\/14651858.CD003961.pub2-BIB0144|cit144","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1034\/j.1399-3046.2001.00062.x","article-title":"Tailoring immunosuppressive therapy for renal transplant recipients","volume":"5","author":"Vanrenterghem","year":"2001","journal-title":"Pediatric Transplantation"},{"issue":"1","key":"10.1002\/14651858.CD003961.pub2-BIB0145|cit145","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003961","article-title":"Tacrolimus for kidney transplant recipients. (Protocol)","author":"Webster","year":"2003","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"7520","key":"10.1002\/14651858.CD003961.pub2-BIB0146|cit146","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1136\/bmj.38569.471007.AE","article-title":"Tacrolimus versus ciclosporin as primary immunosuppression for kidney transplant recipients: meta-analysis and meta-regression of randomised trial data","volume":"331","author":"Webster","year":"2005","journal-title":"BMJ"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD003961.pub2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,4]],"date-time":"2025-01-04T20:59:57Z","timestamp":1736024397000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD003961.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Kidney and Transplant Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2005,10,19]]},"references-count":146,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd003961.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,10,19]]}}}